Sunday, July 28, 2019 1:08:53 PM
For only one example, the information we receive from social media. Many old timers like me are not used to social media and are accustomed to official company press releases only. We only get those every 4-6 weeks, but, CELZ was more active on social media putting out information. I have adapted to watch for that info, others simply refuse and say CELZ is dead silent. They are not if you choose to adapt.
However, I will agree that they have gone much quieter, and I don’t blame them. Every time they bring a doctor on, both sides go on the attack disrupting the office.
I will use my dentist as an example again. When I go in for my 6 month you always see the different products they have for teeth whitening or aligning. That office is simply an end user of the product they are offering. Since my little ole office is using these products, I suspect many other dentists across the country are too. That must bring in decent revs for those teeth product companies, correct?
While there recently I wondered if they were hammered by shareholders of the teeth whitening company when they began to offer their product? I wondered if the company issued a PR when my doctor signed up?
I am sure you see my point. If I was CELZ, I would never announce another office. I would bring them on as fast as I can and let the revs do the talking and let the company grow. Maybe a PR every once in a while announcing they have 15 locations, 25, 50 etc.
The bottom line for me is that CELZ had a nice run to .07 last year on the hope that they would have offices open in the fall. When that didn’t happen, the OTC traders bailed and the PPS tanked to .01
Now, several months later, with several offices open, nothing seems to move the needle. CELZ is under attack from all angles, and IMHO, they have decided to continue with CaverStem, FemCelz and StemSpine without public fanfare. IMHO they don’t care about the PPS because they know it will correct in time. That’s why the CEO has added so many shares. He trusts the PPS will correct. He knows the hard work they are doing. I will follow the money.
I still stand by my belief that the correction will come this summer. The Q2 will show a nice 50% bump in revs and Q3 and Q4 will be even better.
We all know there are several OTC stocks with worse SS and less revs trading in the dimes. When this one is noticed again we will jump to new highs. Whether it starts next week or next month, or next year, it will happen.
Nothing the company is doing is illegal or improper and I welcome all the scrutiny from the frustrated traders. We have all been burned by scams. This clearly is not one. Some have said they have “reported” the company in January, so if true, investigations have been going on for many months.
I am comfortable in my investment and will wait for it to mature. I have said several times it is a marathon, not a sprint. It could have been a sprint, but there was too much headwind.
Stay in, stay out, it does not matter to me one bit. Peace
Recent CELZ News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2023 09:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 01:00:18 PM
- Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements • PR Newswire (US) • 06/28/2023 12:00:00 PM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM